Skip to main content
Clinical Trials/ISRCTN56430072
ISRCTN56430072
Completed
Not Applicable

Exercise training for the treatment of post-thrombotic syndrome: a multicentre, two-arm randomised controlled parallel trial

Sir Mortimer B. Davis Jewish General Hospital (Hôpital Général Juif Sir Mortimer B. Davis) (Canada)0 sites44 target enrollmentMay 9, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Sir Mortimer B. Davis Jewish General Hospital (Hôpital Général Juif Sir Mortimer B. Davis) (Canada)
Enrollment
44
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sir Mortimer B. Davis Jewish General Hospital (Hôpital Général Juif Sir Mortimer B. Davis) (Canada)

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 18 \- 75 years, either sex
  • 2\. Previous unilateral deep vein thrombosis (DVT) diagnosed using standardised ultrasound or venographic criteria
  • 3\. PTS in same leg as previous DVT (Villalta PTS Scale score greater than 4\)

Exclusion Criteria

  • 1\. Acute DVT within previous six months
  • 2\. Contra\-indications to exercise training, e.g. arthritis of lower extremities, angina, symptomatic chronic obstructive lung disease, congestive heart failure, severe claudication, poor balance
  • 3\. Expected lifespan less than six months or general medical condition that would make study unfeasible, e.g. advanced cancer or cardiopulmonary disease
  • 4\. Pregnancy or lactation
  • 5\. Open venous leg ulcer
  • 6\. Not conversant in either English or French
  • 7\. Geographic inaccessibility which precludes participation
  • 8\. Unwilling or unable to provide signed informed consent
  • 9\. Screening (i.e. pre\-randomisation) exercise stress test (Bruce Ramp protocol) demonstrating uncontrolled hypertension, ischaemia, or arrhythmia (such patients will be referred for appropriate medical evaluation)

Outcomes

Primary Outcomes

Not specified

Similar Trials